The Effect of EMLA Cream on Patient-Controlled Analgesia with Remifentanil in ESWL Procedure: A Placebo-Controlled Randomized Study
Author(s):
Abstract:
Background
To alleviate stinging pain in the skin entry area and visceral discomfort in patients who are undergoing ESWL.. Objectives
This study was designed to investigate the effectiveness of the EMLA cream in combination with remifentanil patient-controlled analgesia (PCA) in patients undergoing ESWL treatment.. Patients and Methods
Sixty patients were divided into two double-blind randomized groups. Those in the first group were administered 3-5mm of EMLA 5% cream on a marked area; the second group received، as a placebo، a cream with no analgesic effect in the same amount. All patients were administered a remifentanil bolus with a PCA device. Arterial blood pressure، oxygen saturation، and respiratory rate were recorded throughout the procedure; postoperative side effects، agitation، and respiratory depression were measured after. Visual Analogue Scale (VAS) scores were taken preoperatively، perioperatively، directly postoperatively، and 60 minutes subsequent to finishing the procedure.. Results
There were no statistically significant differences in the frequency of PCA demands and delivered boluses or among perioperative VAS. No significant side effects were noted. Patient satisfaction was recorded high in both groups.. Conclusions
EMLA cream offered no advantage over the placebo cream in patients undergoing ESWL with remifentanil PCA.Keywords:
Lithotripsy , Remifentanil , Analgesia , Patient , Controlled , EMLA
Language:
English
Published:
Anesthesiology and Pain Medicine, Volume:2 Issue: 3, Mar 2013
Page:
119
magiran.com/p1072574
دانلود و مطالعه متن این مقاله با یکی از روشهای زیر امکان پذیر است:
اشتراک شخصی
با عضویت و پرداخت آنلاین حق اشتراک یکساله به مبلغ 1,390,000ريال میتوانید 70 عنوان مطلب دانلود کنید!
اشتراک سازمانی
به کتابخانه دانشگاه یا محل کار خود پیشنهاد کنید تا اشتراک سازمانی این پایگاه را برای دسترسی نامحدود همه کاربران به متن مطالب تهیه نمایند!
توجه!
- حق عضویت دریافتی صرف حمایت از نشریات عضو و نگهداری، تکمیل و توسعه مگیران میشود.
- پرداخت حق اشتراک و دانلود مقالات اجازه بازنشر آن در سایر رسانههای چاپی و دیجیتال را به کاربر نمیدهد.
In order to view content subscription is required
Personal subscription
Subscribe magiran.com for 70 € euros via PayPal and download 70 articles during a year.
Organization subscription
Please contact us to subscribe your university or library for unlimited access!